Related Experiment Video
Updated: Jun 23, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation
M J Weigner1, T A Caulfield, P G Danias
1Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Insights
Cardioversion for atrial fibrillation (AF) under 48 hours is safe, with a low risk of thromboembolism. These findings support current guidelines recommending early cardioversion for short-duration AF.
Area of Science:
- Cardiology
- Electrophysiology
- Internal Medicine
Background:
- Atrial fibrillation (AF) cardioversion is often assumed safe for durations under 48 hours.
- Clinical data supporting this low thromboembolism risk assumption are lacking.
Observation:
- A study of 375 patients with AF <48 hours found 95.2% converted to sinus rhythm.
- Three patients (0.8%) experienced thromboembolic events (stroke, TIA, peripheral embolus) post-conversion.
- These events occurred in patients without prior AF or thromboembolism history and with normal cardiac function.
Findings:
- The incidence of cardioversion-related clinical thromboembolism in patients with AF <48 hours is low.
- The observed thromboembolic event rate was 0.8% (95% CI, 0.2% to 2.4%).
Implications:
- These data support current clinical recommendations for early cardioversion in patients with recent-onset atrial fibrillation.
- The findings reinforce the safety of prompt cardioversion for short-duration AF.
Background:
It has been assumed that cardioversion in patients with atrial fibrillation lasting less than 48 hours is associated with a low risk for thromboembolism. However, no clinical data support this assumption.
Objective:
To determine the incidence of cardioversion-related clinical thromboembolism among patients presenting with atrial fibrillation lasting less than 48 hours.
Design:
Patients were prospectively identified on admission, and clinical data on the duration of atrial fibrillation were recorded. Data on cardioversion and thromboembolism were obtained retrospectively from hospital and outpatient records.
Setting:
Academic medical center.
Patients:
1822 consecutive patients admitted to the hospital for atrial fibrillation were screened. Three hundred seventy-five adults (mean age +/- SD, 68 +/- 16 years) with atrial fibrillation that had lasted less than 48 hours were identified. One hundred eighty-one patients (48.3%) had a history of atrial fibrillation; 23 (6.1%) had a history of thromboembolism.
Results:
357 patients (95.2%) converted to sinus rhythm during the index admission; spontaneous conversion occurred in 250 patients (66.7%) and active pharmacologic or electrical conversion was done in 107 patients (28.5%). Three patients (0.8% [95% CI, 0.2% to 2.4%]), all of whom had converted spontaneously after ventricular rate control was begun, had a clinical thromboembolic event: One had a stroke, 1 had a transient ischemic attack, and 1 had a peripheral embolus. None of these 3 patients had a history of atrial fibrillation or thromboembolism, and all had normal left ventricular systolic function.
Conclusion:
Among patients presenting with atrial fibrillation that was clinically estimated to have lasted less than 48 hours, the likelihood of cardioversion-related clinical thromboembolism is low. These data support the current recommendation for early cardioversion in these patients.
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism, and...
Dysrhythmias II: Classification of Tachyarrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care

